Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors
Meryx, Inc.
Meryx, Inc.
Amgen
Novartis
Wuerzburg University Hospital
Yale University
BBB-Therapeutics B.V.
AVEO Pharmaceuticals, Inc.
Tracon Pharmaceuticals Inc.